By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – US Genomics has raised $1.3 million in a private financing and sold $900,000 in debt instruments, the company disclosed in separate documents filed with the US Securities and Exchange Commission this week.

The Woburn, Mass.-based firm has also changed its name to Pathogenetix.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.